PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Centene Corporation (NYSE:CNC – Free Report) by 8.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 172,730 shares of the company’s stock after purchasing an additional 13,663 shares during the period. PensionDanmark Pensionsforsikringsaktieselskab’s holdings in Centene were worth $11,088,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. DV Equities LLC acquired a new position in Centene during the 4th quarter valued at about $26,000. IFC & Insurance Marketing Inc. acquired a new stake in shares of Centene in the fourth quarter valued at approximately $28,000. SBI Securities Co. Ltd. raised its holdings in shares of Centene by 118.4% during the fourth quarter. SBI Securities Co. Ltd. now owns 749 shares of the company’s stock valued at $31,000 after buying an additional 406 shares during the last quarter. Bayban acquired a new position in shares of Centene during the fourth quarter worth approximately $33,000. Finally, MV Capital Management Inc. bought a new position in Centene in the 4th quarter worth approximately $34,000. Institutional investors and hedge funds own 93.63% of the company’s stock.
Centene Trading Up 2.3%
Shares of CNC stock opened at $65.69 on Friday. The stock has a 50-day simple moving average of $64.48 and a 200 day simple moving average of $50.92. The stock has a market capitalization of $32.45 billion, a P/E ratio of -6.29, a P/E/G ratio of 0.34 and a beta of 1.08. Centene Corporation has a fifty-two week low of $25.18 and a fifty-two week high of $69.36. The company has a quick ratio of 1.15, a current ratio of 1.15 and a debt-to-equity ratio of 0.71.
Analyst Ratings Changes
Several analysts have weighed in on the company. Royal Bank Of Canada lifted their target price on Centene from $70.00 to $71.00 and gave the company a “sector perform” rating in a research note on Thursday, July 9th. The Goldman Sachs Group reissued a “sell” rating and set a $40.00 price target on shares of Centene in a report on Wednesday, April 29th. Truist Financial lifted their price objective on shares of Centene from $71.00 to $78.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Stifel Nicolaus set a $79.00 price objective on shares of Centene in a report on Monday. Finally, Oppenheimer raised their target price on shares of Centene from $58.00 to $67.00 and gave the company an “outperform” rating in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $68.58.
Get Our Latest Analysis on Centene
Centene Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Articles
- Five stocks we like better than Centene
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
